Three things to know:
1. Planning to commercialize the Pure-Vu System and its disposable sleeves, Motus is exploring partnerships with established medical device companies and commercial distributors in the European Union.
2. An estimated 1.2 million inpatient colonoscopies are performed in the EU each year, Motus GI CEO Tim Moran said in a press release.
3. Motus GI’s GEN2 Pure-Vu System is intended to minimize delayed and incomplete colonoscopies, improve exam quality and increase the number of adequately cleansed patients.
More articles on gastroenterology:
Exact Sciences lowers quarterly, full-year outlook due to COVID-19
Baseline colonoscopy results predict 10-year outcomes
CRH Medical’s board chairman resigns — 3 insights